A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved referral rates by 20 percentage points, according to study results.Nearly a third ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment paradigms in ovarian cancer.

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

AROUND 7,500 women are diagnosed with ovarian cancer each year in the UK and 4,100 pass away from it. But symptoms of the ...

COPENHAGEN, Denmark I March 17, 2025 I Genmab A/S (Nasdaq: GMAB) announced today updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart ...

An ovarian cancer campaigner, fundraiser and survivor from Norfolk who has taken her story to parliament, is raising awareness of ovarian cancer and the importance of getting checked if something ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

Ovarian cancer may present a threat to the fallopian tubes and peritoneum. Oncologists Dr. Sai Lakshmi Daayana and Dr. Ajay ...